Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity

Purine nucleosides and ribose- 5-phosphate (Rib- 5-P) were used to modulate the metabolism and cytotoxicity of 5-fluorouracil ( 5-FU) in order to get better understanding of the mechanism of action of 5-FU. In extracts from five different cell lines both Rib- 5-P and inosine were relatively good pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer & clinical oncology 1987-12, Vol.23 (12), p.1869-1881
Hauptverfasser: Peters, Godefridus J., Laurensse, Emile, Leyva, Albert, Pinedo, Herbert M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1881
container_issue 12
container_start_page 1869
container_title European journal of cancer & clinical oncology
container_volume 23
creator Peters, Godefridus J.
Laurensse, Emile
Leyva, Albert
Pinedo, Herbert M.
description Purine nucleosides and ribose- 5-phosphate (Rib- 5-P) were used to modulate the metabolism and cytotoxicity of 5-fluorouracil ( 5-FU) in order to get better understanding of the mechanism of action of 5-FU. In extracts from five different cell lines both Rib- 5-P and inosine were relatively good precursors for Rib- 1-P, but deoxyinosine was a moderate to poor precursor for deoxyRib- 1-P. In the human colon carcinoma WiDr and the human epithelial intestinal Intestine 407 inosine enhanced Rib- 1-P concentrations 3–6-fold. Incubation with deoxyinosine resulted in the appearance of deoxyRib- 1-P in both cell lines in levels comparable to those of Rib- 1-P. dIMP had the same effect as deoxyinosine in Intestine 407 cells, but not in WiDr cells. Both inosine and deoxyinosine caused a depletion of phosphoribosyl-pyrophosphate. In WiDr cells deoxyinosine (0.1–1.0 mM) clearly potentiated the growth inhibition by 0.1–0.5 μM 5-FU after 24 h of culture, but growth between 24 and 48 h was normal. In Intestine 407 cells the potentiation of 5-FU cytotoxicity by deoxyinosine was even more pronounced at 48 h than at 24 h. In WiDr cells dIMP did not potentiate 5-FU cytotoxity, but in Intestine 407 cells the effect was comparable to that of deoxyinosine. The lack of potentiation in WiDr was accompanied by a low metabolism of dIMP. Growth inhibition by 5-FU and deoxyinosine could be reversed by thymidine in Intestine 407 cells but not completely in WiDr cells. Since the predominant target of the deoxyinosine- 5-FU combination was thymidylate synthase, we analyzed the inhibition of this enzyme by FdUMP and the retention of the inhibition in cell culture. In both cell lines FdUMP was a potent competitive inhibitor of thymidylate synthase with a K i of between 0.5 and 2 nM. Culture of cells in the presence of 5-FU and deoxyinosine resulted in an almost complete inhibition of thymidylate synthase activity after 24 h but after 48 h the activity was partly recovered. In Intestine 407 cells replenishment of the culture medium at 24 h even enhanced the recovery. Analysis of 5-FU anabolism into nucleic acids demonstrated that deoxyinosine inhibited the incorporation of 5-FU into RNA. It is concluded that in Intestine 407 cells addition of deoxyinosine enhanced the effects of 5-FU on growth inhibition due to increased formation of FdUMP leading to enhanced inhibition of thymidylate synthase. In WiDr cells incorporation of 5-FU into RNA might also contribute significantly to cytotoxicity
doi_str_mv 10.1016/0277-5379(87)90053-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77934130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0277537987900538</els_id><sourcerecordid>77934130</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3768-b90e4a73ff7dbcf9db8683114afada941b5044ae5c3a5fccac5f26b58d184b3b3</originalsourceid><addsrcrecordid>eNqFkE2LFDEQhnNQ1nX1HyjkIKKH1mSSdNIXQRa_YEEPehNCpVKBSHdnTLrF-fdOO8Mc9VRQ9bxF1cPYEyleSSH712JnbWeUHV44-3IQwqjO3WPXl_YD9rC1H0LsnDbqil0prXpl5DX7_mWteSY-rzhSaTlS49A40jh2bU-YU0Y-lbiOsJTaeEncdGlcSy1rBcwjn2iBUMbcJg5z5HhYylJ-Z8zL4RG7n2Bs9Phcb9i39---3n7s7j5_-HT79q5DZXvXhUGQBqtSsjFgGmJwvVNSakgQYdAyGKE1kEEFJiECmrTrg3FROh1UUDfs-WnvvpafK7XFT7ltL8BMZW3e2kFpqcQR1CcQa2mtUvL7mieoBy-F30T6zZjfjHln_V-R3h1jT8_71zBRvITOFo_zZ-c5NIQxVZgxtwtmtdPK2P9iwmppN-zNCaOjsl-Zqm-YaUaKuRIuPpb873P_AJhKn-I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77934130</pqid></control><display><type>article</type><title>Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Peters, Godefridus J. ; Laurensse, Emile ; Leyva, Albert ; Pinedo, Herbert M.</creator><creatorcontrib>Peters, Godefridus J. ; Laurensse, Emile ; Leyva, Albert ; Pinedo, Herbert M.</creatorcontrib><description>Purine nucleosides and ribose- 5-phosphate (Rib- 5-P) were used to modulate the metabolism and cytotoxicity of 5-fluorouracil ( 5-FU) in order to get better understanding of the mechanism of action of 5-FU. In extracts from five different cell lines both Rib- 5-P and inosine were relatively good precursors for Rib- 1-P, but deoxyinosine was a moderate to poor precursor for deoxyRib- 1-P. In the human colon carcinoma WiDr and the human epithelial intestinal Intestine 407 inosine enhanced Rib- 1-P concentrations 3–6-fold. Incubation with deoxyinosine resulted in the appearance of deoxyRib- 1-P in both cell lines in levels comparable to those of Rib- 1-P. dIMP had the same effect as deoxyinosine in Intestine 407 cells, but not in WiDr cells. Both inosine and deoxyinosine caused a depletion of phosphoribosyl-pyrophosphate. In WiDr cells deoxyinosine (0.1–1.0 mM) clearly potentiated the growth inhibition by 0.1–0.5 μM 5-FU after 24 h of culture, but growth between 24 and 48 h was normal. In Intestine 407 cells the potentiation of 5-FU cytotoxicity by deoxyinosine was even more pronounced at 48 h than at 24 h. In WiDr cells dIMP did not potentiate 5-FU cytotoxity, but in Intestine 407 cells the effect was comparable to that of deoxyinosine. The lack of potentiation in WiDr was accompanied by a low metabolism of dIMP. Growth inhibition by 5-FU and deoxyinosine could be reversed by thymidine in Intestine 407 cells but not completely in WiDr cells. Since the predominant target of the deoxyinosine- 5-FU combination was thymidylate synthase, we analyzed the inhibition of this enzyme by FdUMP and the retention of the inhibition in cell culture. In both cell lines FdUMP was a potent competitive inhibitor of thymidylate synthase with a K i of between 0.5 and 2 nM. Culture of cells in the presence of 5-FU and deoxyinosine resulted in an almost complete inhibition of thymidylate synthase activity after 24 h but after 48 h the activity was partly recovered. In Intestine 407 cells replenishment of the culture medium at 24 h even enhanced the recovery. Analysis of 5-FU anabolism into nucleic acids demonstrated that deoxyinosine inhibited the incorporation of 5-FU into RNA. It is concluded that in Intestine 407 cells addition of deoxyinosine enhanced the effects of 5-FU on growth inhibition due to increased formation of FdUMP leading to enhanced inhibition of thymidylate synthase. In WiDr cells incorporation of 5-FU into RNA might also contribute significantly to cytotoxicity.</description><identifier>ISSN: 0277-5379</identifier><identifier>DOI: 10.1016/0277-5379(87)90053-8</identifier><identifier>PMID: 3436351</identifier><identifier>CODEN: EJCODS</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>5,10-CH 2FH 4, 5,10-methylene tetrahydrofolate ; 5-FU, 5-fluorouracil ; Animals ; Antineoplastic agents ; Applied sciences ; Biological and medical sciences ; Cell Division - drug effects ; Cell Line ; dRib-1-P, deoxy-ribose-1-phosphate ; Exact sciences and technology ; FdUMP, 5-fluoro-2′-deoxyuridine-5′-monophosphate ; Fluorouracil - metabolism ; Fluorouracil - pharmacology ; FUdR, 5-fluorodeoxyuridine ; FUMP, 5-fluoro-uridine-5′-monophosphate ; FUR, 5-fluorouridine ; General aspects ; IC50, concentration that causes 50% growth inhibition ; Medical sciences ; OPRT, orotate phosphoribosyl transferase ; Other techniques and industries ; Pentosephosphates - pharmacology ; Pharmacology. Drug treatments ; PRPP, 5-phosphoribosyl-1-pyrophosphate ; Purine Nucleosides - pharmacology ; Rib-1-P, ribose-1-phosphate ; Rib-5-P, ribose-5-phosphate ; Ribosemonophosphates - pharmacology ; TCA, trichloroacetic acid ; Thymidine - pharmacology ; Thymidylate Synthase - antagonists &amp; inhibitors ; Tumor Cells, Cultured - drug effects</subject><ispartof>European journal of cancer &amp; clinical oncology, 1987-12, Vol.23 (12), p.1869-1881</ispartof><rights>1987</rights><rights>1989 INIST-CNRS</rights><rights>1988 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3768-b90e4a73ff7dbcf9db8683114afada941b5044ae5c3a5fccac5f26b58d184b3b3</citedby><cites>FETCH-LOGICAL-c3768-b90e4a73ff7dbcf9db8683114afada941b5044ae5c3a5fccac5f26b58d184b3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7074177$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7484357$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3436351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peters, Godefridus J.</creatorcontrib><creatorcontrib>Laurensse, Emile</creatorcontrib><creatorcontrib>Leyva, Albert</creatorcontrib><creatorcontrib>Pinedo, Herbert M.</creatorcontrib><title>Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity</title><title>European journal of cancer &amp; clinical oncology</title><addtitle>Eur J Cancer Clin Oncol</addtitle><description>Purine nucleosides and ribose- 5-phosphate (Rib- 5-P) were used to modulate the metabolism and cytotoxicity of 5-fluorouracil ( 5-FU) in order to get better understanding of the mechanism of action of 5-FU. In extracts from five different cell lines both Rib- 5-P and inosine were relatively good precursors for Rib- 1-P, but deoxyinosine was a moderate to poor precursor for deoxyRib- 1-P. In the human colon carcinoma WiDr and the human epithelial intestinal Intestine 407 inosine enhanced Rib- 1-P concentrations 3–6-fold. Incubation with deoxyinosine resulted in the appearance of deoxyRib- 1-P in both cell lines in levels comparable to those of Rib- 1-P. dIMP had the same effect as deoxyinosine in Intestine 407 cells, but not in WiDr cells. Both inosine and deoxyinosine caused a depletion of phosphoribosyl-pyrophosphate. In WiDr cells deoxyinosine (0.1–1.0 mM) clearly potentiated the growth inhibition by 0.1–0.5 μM 5-FU after 24 h of culture, but growth between 24 and 48 h was normal. In Intestine 407 cells the potentiation of 5-FU cytotoxicity by deoxyinosine was even more pronounced at 48 h than at 24 h. In WiDr cells dIMP did not potentiate 5-FU cytotoxity, but in Intestine 407 cells the effect was comparable to that of deoxyinosine. The lack of potentiation in WiDr was accompanied by a low metabolism of dIMP. Growth inhibition by 5-FU and deoxyinosine could be reversed by thymidine in Intestine 407 cells but not completely in WiDr cells. Since the predominant target of the deoxyinosine- 5-FU combination was thymidylate synthase, we analyzed the inhibition of this enzyme by FdUMP and the retention of the inhibition in cell culture. In both cell lines FdUMP was a potent competitive inhibitor of thymidylate synthase with a K i of between 0.5 and 2 nM. Culture of cells in the presence of 5-FU and deoxyinosine resulted in an almost complete inhibition of thymidylate synthase activity after 24 h but after 48 h the activity was partly recovered. In Intestine 407 cells replenishment of the culture medium at 24 h even enhanced the recovery. Analysis of 5-FU anabolism into nucleic acids demonstrated that deoxyinosine inhibited the incorporation of 5-FU into RNA. It is concluded that in Intestine 407 cells addition of deoxyinosine enhanced the effects of 5-FU on growth inhibition due to increased formation of FdUMP leading to enhanced inhibition of thymidylate synthase. In WiDr cells incorporation of 5-FU into RNA might also contribute significantly to cytotoxicity.</description><subject>5,10-CH 2FH 4, 5,10-methylene tetrahydrofolate</subject><subject>5-FU, 5-fluorouracil</subject><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Applied sciences</subject><subject>Biological and medical sciences</subject><subject>Cell Division - drug effects</subject><subject>Cell Line</subject><subject>dRib-1-P, deoxy-ribose-1-phosphate</subject><subject>Exact sciences and technology</subject><subject>FdUMP, 5-fluoro-2′-deoxyuridine-5′-monophosphate</subject><subject>Fluorouracil - metabolism</subject><subject>Fluorouracil - pharmacology</subject><subject>FUdR, 5-fluorodeoxyuridine</subject><subject>FUMP, 5-fluoro-uridine-5′-monophosphate</subject><subject>FUR, 5-fluorouridine</subject><subject>General aspects</subject><subject>IC50, concentration that causes 50% growth inhibition</subject><subject>Medical sciences</subject><subject>OPRT, orotate phosphoribosyl transferase</subject><subject>Other techniques and industries</subject><subject>Pentosephosphates - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>PRPP, 5-phosphoribosyl-1-pyrophosphate</subject><subject>Purine Nucleosides - pharmacology</subject><subject>Rib-1-P, ribose-1-phosphate</subject><subject>Rib-5-P, ribose-5-phosphate</subject><subject>Ribosemonophosphates - pharmacology</subject><subject>TCA, trichloroacetic acid</subject><subject>Thymidine - pharmacology</subject><subject>Thymidylate Synthase - antagonists &amp; inhibitors</subject><subject>Tumor Cells, Cultured - drug effects</subject><issn>0277-5379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE2LFDEQhnNQ1nX1HyjkIKKH1mSSdNIXQRa_YEEPehNCpVKBSHdnTLrF-fdOO8Mc9VRQ9bxF1cPYEyleSSH712JnbWeUHV44-3IQwqjO3WPXl_YD9rC1H0LsnDbqil0prXpl5DX7_mWteSY-rzhSaTlS49A40jh2bU-YU0Y-lbiOsJTaeEncdGlcSy1rBcwjn2iBUMbcJg5z5HhYylJ-Z8zL4RG7n2Bs9Phcb9i39---3n7s7j5_-HT79q5DZXvXhUGQBqtSsjFgGmJwvVNSakgQYdAyGKE1kEEFJiECmrTrg3FROh1UUDfs-WnvvpafK7XFT7ltL8BMZW3e2kFpqcQR1CcQa2mtUvL7mieoBy-F30T6zZjfjHln_V-R3h1jT8_71zBRvITOFo_zZ-c5NIQxVZgxtwtmtdPK2P9iwmppN-zNCaOjsl-Zqm-YaUaKuRIuPpb873P_AJhKn-I</recordid><startdate>198712</startdate><enddate>198712</enddate><creator>Peters, Godefridus J.</creator><creator>Laurensse, Emile</creator><creator>Leyva, Albert</creator><creator>Pinedo, Herbert M.</creator><general>Elsevier Ltd</general><general>Pergamon Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198712</creationdate><title>Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity</title><author>Peters, Godefridus J. ; Laurensse, Emile ; Leyva, Albert ; Pinedo, Herbert M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3768-b90e4a73ff7dbcf9db8683114afada941b5044ae5c3a5fccac5f26b58d184b3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>5,10-CH 2FH 4, 5,10-methylene tetrahydrofolate</topic><topic>5-FU, 5-fluorouracil</topic><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Applied sciences</topic><topic>Biological and medical sciences</topic><topic>Cell Division - drug effects</topic><topic>Cell Line</topic><topic>dRib-1-P, deoxy-ribose-1-phosphate</topic><topic>Exact sciences and technology</topic><topic>FdUMP, 5-fluoro-2′-deoxyuridine-5′-monophosphate</topic><topic>Fluorouracil - metabolism</topic><topic>Fluorouracil - pharmacology</topic><topic>FUdR, 5-fluorodeoxyuridine</topic><topic>FUMP, 5-fluoro-uridine-5′-monophosphate</topic><topic>FUR, 5-fluorouridine</topic><topic>General aspects</topic><topic>IC50, concentration that causes 50% growth inhibition</topic><topic>Medical sciences</topic><topic>OPRT, orotate phosphoribosyl transferase</topic><topic>Other techniques and industries</topic><topic>Pentosephosphates - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>PRPP, 5-phosphoribosyl-1-pyrophosphate</topic><topic>Purine Nucleosides - pharmacology</topic><topic>Rib-1-P, ribose-1-phosphate</topic><topic>Rib-5-P, ribose-5-phosphate</topic><topic>Ribosemonophosphates - pharmacology</topic><topic>TCA, trichloroacetic acid</topic><topic>Thymidine - pharmacology</topic><topic>Thymidylate Synthase - antagonists &amp; inhibitors</topic><topic>Tumor Cells, Cultured - drug effects</topic><toplevel>online_resources</toplevel><creatorcontrib>Peters, Godefridus J.</creatorcontrib><creatorcontrib>Laurensse, Emile</creatorcontrib><creatorcontrib>Leyva, Albert</creatorcontrib><creatorcontrib>Pinedo, Herbert M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer &amp; clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peters, Godefridus J.</au><au>Laurensse, Emile</au><au>Leyva, Albert</au><au>Pinedo, Herbert M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity</atitle><jtitle>European journal of cancer &amp; clinical oncology</jtitle><addtitle>Eur J Cancer Clin Oncol</addtitle><date>1987-12</date><risdate>1987</risdate><volume>23</volume><issue>12</issue><spage>1869</spage><epage>1881</epage><pages>1869-1881</pages><issn>0277-5379</issn><coden>EJCODS</coden><abstract>Purine nucleosides and ribose- 5-phosphate (Rib- 5-P) were used to modulate the metabolism and cytotoxicity of 5-fluorouracil ( 5-FU) in order to get better understanding of the mechanism of action of 5-FU. In extracts from five different cell lines both Rib- 5-P and inosine were relatively good precursors for Rib- 1-P, but deoxyinosine was a moderate to poor precursor for deoxyRib- 1-P. In the human colon carcinoma WiDr and the human epithelial intestinal Intestine 407 inosine enhanced Rib- 1-P concentrations 3–6-fold. Incubation with deoxyinosine resulted in the appearance of deoxyRib- 1-P in both cell lines in levels comparable to those of Rib- 1-P. dIMP had the same effect as deoxyinosine in Intestine 407 cells, but not in WiDr cells. Both inosine and deoxyinosine caused a depletion of phosphoribosyl-pyrophosphate. In WiDr cells deoxyinosine (0.1–1.0 mM) clearly potentiated the growth inhibition by 0.1–0.5 μM 5-FU after 24 h of culture, but growth between 24 and 48 h was normal. In Intestine 407 cells the potentiation of 5-FU cytotoxicity by deoxyinosine was even more pronounced at 48 h than at 24 h. In WiDr cells dIMP did not potentiate 5-FU cytotoxity, but in Intestine 407 cells the effect was comparable to that of deoxyinosine. The lack of potentiation in WiDr was accompanied by a low metabolism of dIMP. Growth inhibition by 5-FU and deoxyinosine could be reversed by thymidine in Intestine 407 cells but not completely in WiDr cells. Since the predominant target of the deoxyinosine- 5-FU combination was thymidylate synthase, we analyzed the inhibition of this enzyme by FdUMP and the retention of the inhibition in cell culture. In both cell lines FdUMP was a potent competitive inhibitor of thymidylate synthase with a K i of between 0.5 and 2 nM. Culture of cells in the presence of 5-FU and deoxyinosine resulted in an almost complete inhibition of thymidylate synthase activity after 24 h but after 48 h the activity was partly recovered. In Intestine 407 cells replenishment of the culture medium at 24 h even enhanced the recovery. Analysis of 5-FU anabolism into nucleic acids demonstrated that deoxyinosine inhibited the incorporation of 5-FU into RNA. It is concluded that in Intestine 407 cells addition of deoxyinosine enhanced the effects of 5-FU on growth inhibition due to increased formation of FdUMP leading to enhanced inhibition of thymidylate synthase. In WiDr cells incorporation of 5-FU into RNA might also contribute significantly to cytotoxicity.</abstract><cop>Oxford</cop><cop>New York, NY</cop><pub>Elsevier Ltd</pub><pmid>3436351</pmid><doi>10.1016/0277-5379(87)90053-8</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0277-5379
ispartof European journal of cancer & clinical oncology, 1987-12, Vol.23 (12), p.1869-1881
issn 0277-5379
language eng
recordid cdi_proquest_miscellaneous_77934130
source MEDLINE; Alma/SFX Local Collection
subjects 5,10-CH 2FH 4, 5,10-methylene tetrahydrofolate
5-FU, 5-fluorouracil
Animals
Antineoplastic agents
Applied sciences
Biological and medical sciences
Cell Division - drug effects
Cell Line
dRib-1-P, deoxy-ribose-1-phosphate
Exact sciences and technology
FdUMP, 5-fluoro-2′-deoxyuridine-5′-monophosphate
Fluorouracil - metabolism
Fluorouracil - pharmacology
FUdR, 5-fluorodeoxyuridine
FUMP, 5-fluoro-uridine-5′-monophosphate
FUR, 5-fluorouridine
General aspects
IC50, concentration that causes 50% growth inhibition
Medical sciences
OPRT, orotate phosphoribosyl transferase
Other techniques and industries
Pentosephosphates - pharmacology
Pharmacology. Drug treatments
PRPP, 5-phosphoribosyl-1-pyrophosphate
Purine Nucleosides - pharmacology
Rib-1-P, ribose-1-phosphate
Rib-5-P, ribose-5-phosphate
Ribosemonophosphates - pharmacology
TCA, trichloroacetic acid
Thymidine - pharmacology
Thymidylate Synthase - antagonists & inhibitors
Tumor Cells, Cultured - drug effects
title Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T04%3A46%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purine%20nucleosides%20as%20cell-specific%20modulators%20of%205-fluorouracil%20metabolism%20and%20cytotoxicity&rft.jtitle=European%20journal%20of%20cancer%20&%20clinical%20oncology&rft.au=Peters,%20Godefridus%20J.&rft.date=1987-12&rft.volume=23&rft.issue=12&rft.spage=1869&rft.epage=1881&rft.pages=1869-1881&rft.issn=0277-5379&rft.coden=EJCODS&rft_id=info:doi/10.1016/0277-5379(87)90053-8&rft_dat=%3Cproquest_cross%3E77934130%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77934130&rft_id=info:pmid/3436351&rft_els_id=0277537987900538&rfr_iscdi=true